Easywell Biomedicals, Inc. (TPEX: 1799)
Health Care · Pharmaceuticals · TW
NT$30.20
+0.17% today · -33.6% 1Y
Easywell Biomedicals, Inc. (TPEX: 1799) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $118.26M and employs 3,118 people.
Over the last twelve months the share price has lost 33.6%, trading between 27.65 and 55.20.
Tweenvest scores Easywell Biomedicals, Inc. across four factors: quality 56/100, value 68/100. Its strongest factor is value.
1799 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $118.26M
- Revenue (TTM)
- $25.14M
- P/E
- —
- EPS
- -0.12
- Dividend yield
- —
- Beta (5Y)
- -0.12
- 52-week high
- NT$55.20
- 52-week low
- NT$27.65
- Avg volume (3M)
- —
- Shares outstanding
- 124.69M
- Employees
- 3,118
- Next earnings
- —
About Easywell Biomedicals, Inc.
Easywell Biomedicals, Inc., together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients and over-the-counter drug products in America. It operates through Drug Development and Other segments. The company develops TLX-001, an anti-cough medicine; TLX-005, an anti-urinary incontinence medicine; TLX-006 for treatment of breast cancer in PMS women; TLX-007 and TLX-004, an anti-depressant; TLX-008 for prevention of pneumocystis pneumonia; TLX-012 for treatment of epilepsy; TLX-017 for treatment of chronic angina; TLX-011 for treatment of inflammatory lesions of rosacea; TLX-015 a prevention and treatment medicine for postpartum hemorrhage; TLX-018, a hemorrhage treatment drug; TLX-030, an anti-inflammatory medicine; TLX-47, an anti-inflammatory drug; and TLX-024, an anticonvulsant. It also develops TWB-201 for Parkinson patch; TLX-501, a urinary medicine; and TLX-502, a pneumonia medicine. In addition, the company provides thermometers, medical devices, and health food and products. It has a collaborative development agreement with Handa Pharmaceuticals and Handa Neuroscience, LLC for the development of TLX-050 for the treatment of neurological disorders. The company was formerly known as Actherm Inc. and changed its name to Easywell Biomedicals, Inc. in July 2015. Easywell Biomedicals, Inc. was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan.
- ISIN
- TW0001799005
- Founded
- 1998
- Listed since
- Dec 31, 2007
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,235.20 | +0.12% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.56 | +0.15% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.26 | -0.12% |
| Roche Holding AGSWX: ROP | $371.62B | CHF374.20 | +0.11% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.68 | -0.87% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.